PatternsRadar
Sign in

FDCFDC Limited

NSE
377.55INR-0.50 (-0.13%)Close · 20 Nov 2026
27 Oct 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹6,147 CrMarket cap
19.6P/E (TTM)
28.5%Delivery

Filings & corporate actions

78 results filed
CSV
Next results · Q3 FY27
Expected 5 Feb 2027 – 13 Feb 2027
Estimate: filed 36–44 days after quarter end, last 5 times
Dividend
₹5.00 per share · last 11 Feb 2026
2026
  • 13 NovbuybackBuy Back · record 13 Nov 2026-4.7%
  • 27 OctresultsResults · Q2 FY27 · consolidated and standalone+6.4%NSE
  • 17 OctshareholdingShareholding · 30 Sept 2026-3.6%NSE
  • 5 AugresultsResults · Q1 FY27 · consolidated and standalone-4.5%NSE
  • 17 JulshareholdingShareholding · 30 Jun 2026-0.4%NSE
  • 17 JulresultsResults · Q4 FY26 · consolidated and standalone-0.5%NSE
  • 27 MayresultsResults · Q4 FY26 · consolidated and standalone-5.7%NSE
  • 14 AprshareholdingShareholding · 31 Mar 2026+0.9%NSE
  • 11 FebdividendDividend · ₹5.00 per share-1.0%
  • 5 FebresultsResults · Q3 FY26 · consolidated and standalone-2.7%NSE
  • 16 JanshareholdingShareholding · 31 Dec 2025-1.2%NSE

Reaction to results · all yearsrose on day 0 in 33 of 76 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2727 Oct 2026+6.4%+10.5%—14.2×
Q1 FY275 Aug 2026-4.5%-7.4%-11.9%3.6×
Q4 FY2627 May 2026-5.7%-11.3%-2.1%7.1×
Q3 FY265 Feb 2026-2.7%-0.6%-1.7%3.1×
Q2 FY265 Nov 2025-5.7%-8.3%-7.4%5.8×
Q1 FY267 Aug 2025-0.5%-0.1%-4.1%1.9×
Q4 FY2528 May 2025-3.0%-4.8%+4.0%8.6×
Q3 FY2513 Feb 2025-7.0%-6.9%-9.3%10.1×
Q2 FY257 Nov 2024-5.2%-9.3%-6.4%1.2×
Q1 FY258 Aug 2024-3.3%-7.0%+10.3%1.4×
Q4 FY2430 May 2024-1.3%-6.4%-0.7%3.6×
Q3 FY248 Feb 2024-3.3%-2.4%-3.1%1.4×
Q2 FY249 Nov 2023+5.5%+7.2%+10.3%8.8×
Q1 FY2410 Aug 2023+5.1%+0.1%+2.2%8.3×
Q4 FY2326 May 2023+1.9%+2.6%+11.8%1.4×
Q3 FY2310 Feb 2023+0.1%+1.0%-5.0%1.3×
Q2 FY2315 Nov 2022-4.6%-6.3%-5.7%2.2×
Q1 FY235 Aug 2022+5.8%+3.3%+8.7%9.7×
Q4 FY2226 May 2022+1.4%+0.7%-4.2%0.4×
Q3 FY229 Feb 2022-4.2%-3.9%-13.3%3.3×
Q2 FY2211 Nov 2021-3.5%-13.0%-7.3%2.5×
Q1 FY2213 Aug 2021-1.4%-8.3%-0.5%1.6×
Q4 FY2126 May 2021-5.3%-3.0%+0.6%3.9×
Q3 FY214 Feb 2021-5.7%-5.0%-7.2%2.5×
Q2 FY219 Nov 2020+0.8%-2.3%+7.6%1.5×
Q1 FY217 Aug 2020+2.7%-2.4%-4.7%1.2×
Q4 FY2017 Jun 2020+1.7%+9.4%+4.2%3.4×
Q3 FY207 Feb 2020+7.0%+2.6%-4.8%9.8×
Q2 FY208 Nov 2019+1.4%+11.5%+16.3%5.5×
Q1 FY203 Aug 2019+4.2%+3.5%+4.3%4.0×
Q4 FY1924 May 2019+2.3%+0.2%-11.3%4.0×
Q3 FY1913 Feb 2019-3.1%-6.9%+10.7%0.8×
Q2 FY1926 Nov 2018+1.3%+2.2%-6.0%36.0×
Q1 FY198 Aug 2018-0.3%+2.2%+3.8%0.9×
Q4 FY1820 Jun 2018-2.6%-7.5%-3.9%2.0×
Q3 FY1814 Feb 2018-2.0%-2.7%-6.6%1.1×
Q2 FY1821 Nov 2017+3.1%+0.7%+2.3%6.4×
Q1 FY187 Aug 2017-2.0%-3.8%-4.1%1.1×
Q4 FY1730 May 2017+2.3%+2.8%+1.9%1.2×
Q3 FY176 Feb 2017-0.2%+0.2%-0.1%0.9×
Q2 FY1717 Nov 2016+2.9%+1.2%+6.2%1.1×
Q1 FY1723 Sept 2016-0.4%-0.9%+1.5%0.1×
Q4 FY1629 May 2016-0.1%-4.0%-2.9%2.0×
Q3 FY168 Feb 2016-3.4%-3.8%+0.6%0.9×
Q2 FY169 Nov 2015-0.2%+0.9%-0.5%0.6×
Q1 FY167 Aug 2015-3.4%+0.4%+2.4%0.6×
Q4 FY1529 May 2015-1.1%-2.1%-4.7%0.7×
Q3 FY1510 Feb 20150.0%+0.1%+0.9%0.4×
Q2 FY1521 Nov 2014-1.3%-4.6%-0.3%0.6×
Q1 FY158 Aug 2014+0.3%+1.1%+21.9%0.8×
Q4 FY146 Jun 2014+0.6%+1.1%+15.3%1.0×
Q3 FY1431 Jan 2014-0.8%-4.4%+4.7%0.8×
Q2 FY147 Nov 2013-1.3%-2.1%+17.5%0.3×
Q1 FY147 Aug 2013+1.9%-0.1%-0.5%0.3×
Q4 FY1329 May 2013+0.2%+1.5%+2.8%1.0×
Q3 FY134 Feb 2013-0.2%-1.7%-2.5%0.6×
Q2 FY135 Nov 2012+1.8%+4.3%+0.4%1.8×
Q1 FY137 Aug 2012+2.0%+1.4%+1.5%3.7×
Q4 FY1228 May 2012+3.6%-4.1%-5.4%35.3×
Q3 FY121 Feb 2012-2.0%-0.1%-2.0%3.2×
Q2 FY121 Nov 2011-2.9%-8.1%-17.8%4.7×
Q1 FY128 Aug 2011-1.8%-4.2%-2.4%1.5×
Q3 FY1127 Jan 2011-1.9%-4.8%-0.9%3.7×
Q2 FY1130 Oct 2010+0.9%+4.7%-4.4%0.6×
Q1 FY1127 Jul 2010-5.0%-7.6%-9.8%1.5×
Q3 FY1027 Jan 2010+6.3%+17.0%+8.3%2.0×
Q2 FY1029 Oct 2009+9.2%+6.9%+13.5%5.0×
Q1 FY1030 Jul 2009+3.4%-0.2%+9.0%2.2×
Q3 FY0929 Jan 2009+1.6%+2.7%+8.0%0.2×
Q2 FY0925 Oct 2008-4.1%+7.3%+16.5%0.8×
Q1 FY0926 Jul 2008+20.1%+34.2%+24.2%10.9×
Q4 FY0828 Jun 2008-6.1%-7.0%+16.1%0.7×
Q3 FY0828 Jan 2008+4.6%+6.7%-3.5%0.3×
Q2 FY0827 Oct 2007+0.3%-5.3%+7.3%1.5×
Q1 FY0831 Jul 2007-1.2%-0.2%-4.6%1.4×
Q4 FY0726 Jun 2007-4.9%-5.2%-12.7%1.8×
Average-0.1%-0.6%+1.0%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+21.0%
Profit YoY+72.9%
Interest cost YoY-2.7%
Revenue QoQ-14.3%
Profit QoQ-63.0%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+5.1%+7.0%+9.0%+8.8%+9.4%—
Profit-0.6%+7.6%+16.7%+1.4%+0.2%—

Key data

Open373.90
Day range372.50 – 380.40
52-week range312.95 – 442.00
From 52w high-14.6%
RSI (14)54.2
ATR (14)10.26
Volume98.5K
Avg volume (20D)2.96L
Rel volume0.33×
Volatility (1Y)29.8%
Turnover₹3.7Cr
Traded value (NSE)₹3.7Cr
VWAP377.60
SMA 50 / 200358.33 / 371.23
Price band20%

Delivery percentage

Latest · 20 Nov 202628.5%
20-day avg50.7%
1-year avg54.4%
Percentile (own history)3rd
Range7.7–98.5%
Sessions3,629

Over the last 20 sessions FDC settled 50.7% of its traded quantity, which is above average for an NSE equity. Its one-year average is 54.4%, so recent sessions are running 3.6 points lower than usual. The latest session ranks higher than 3% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield1.32%
Dividend, trailing 12M₹5.00
Paid every year for1 yr
Shareholders54.6K · -0.8% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy799 days ago

Performance returns

1D1W1M3M6M1Y
Price-0.13%+1.46%+10.90%+7.83%+4.18%-7.64%

Valuation

Market cap₹6,147 Cr
Market cap (NSE)₹6,147 Cr
Free-float cap₹1,865 Cr
P/E (TTM)19.6
P/E (NSE)19.6
EPS (TTM)19.24
P/B2.3
Net margin (TTM)13.7%
Other income / PBT32.7%
ROE12.3%
Debt / equity0.00
Shares outstanding16.28Cr
Listed7 Aug 1997

Ownership

Promoter69.66%
Promoter Δ QoQ0.00 pp
Public30.34%
FII1.58%
DII6.59%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)464.7584.8667.7572.1
YoY chg+0.1%+18.9%+3.0%+21.0%
Net profit (₹ Cr)28.3103.4132.549.1
YoY chg-23.6%+167.4%+9.2%+72.9%
Net margin6.1%17.7%19.8%8.6%
EPS1.746.358.143.01

Shareholding over time

By quarter

30 Sept 2026 · promoter 69.66% · public 30.34%
30 Sept 2021: promoter 69.35%31 Dec 2021: promoter 69.36%31 Mar 2022: promoter 69.36%30 Jun 2022: promoter 69.50%30 Sept 2022: promoter 69.50%31 Dec 2022: promoter 69.50%31 Mar 2023: promoter 69.50%30 Jun 2023: promoter 69.50%30 Sept 2023: promoter 69.66%31 Dec 2023: promoter 69.66%31 Mar 2024: promoter 69.66%30 Jun 2024: promoter 69.66%30 Sept 2024: promoter 69.66%31 Dec 2024: promoter 69.66%31 Mar 2025: promoter 69.66%30 Jun 2025: promoter 69.66%30 Sept 2025: promoter 69.66%31 Dec 2025: promoter 69.66%31 Mar 2026: promoter 69.66%30 Jun 2026: promoter 69.66%30 Sept 2026: promoter 69.66%
2021-092026-09
  • Promoter
  • Public and others
Promoter
69.66%
Public
30.34%
Promoter change
0.00 pp
Filed
17 Oct 2026
FII
1.58%
DII
6.59%
Promoter pledged
0.00%

Who the public is

Mutual funds
6.48%

+0.23 pp QoQ

Insurance
0.06%

0.00 pp QoQ

FPI
1.57%

+0.17 pp QoQ

Retail ≤ ₹2L
13.07%

-0.34 pp QoQ

HNI > ₹2L
4.15%

-0.08 pp QoQ

NRI
1.79%

-0.07 pp QoQ

Bodies corporate
2.26%

+0.19 pp QoQ

Shareholders
54,621

-0.8% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
NOMITA R CHANDAVARKARPromoter · Individual22.67%
NANDAN MOHAN CHANDAVARKAR (In the capacity of Trustee of Sandhya Mohan Chandavarkar Trust)Promoter · Individual12.45%
NANDAN MOHAN CHANDAVARKAR (In the capacity of Trustee of Mohan Anand Chandavarkar Trust)Promoter · Individual12.45%
Leo Advisors Private Limited (In capacity of Trsutee of Ameya Family Discretionary Trust)Promoter · Corporate9.17%
ADITI C BHANOTPromoter · Individual6.80%
AMEYA ASHOK CHANDAVARKARPromoter · Individual6.10%
ICICI PRUDENTIAL SMALLCAP FUNDMutual fund2.91%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUNDMutual fund2.63%
NANDAN MOHAN CHANDAVARKARPromoter · Individual0.01%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 6 Aug 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2025-261₹5.00₹5.00
FY2024-251₹5.00₹5.00
FY2019-201₹0.80₹0.80
FY2017-181₹2.25₹2.25
FY2015-162₹4.50₹4.50
FY2014-151₹2.25₹2.25
FY2013-141₹2.25₹2.25
FY2012-131₹2.00₹2.00
Ex-dateRecord dateDeclaredAdjusted
11 Feb 2026—₹5.00₹5.00
22 Nov 2024—₹5.00₹5.00
19 Mar 2020—₹0.80₹0.80
8 Aug 2017—₹2.25₹2.25
17 Mar 2016—₹2.25₹2.25
23 Sept 2015—₹2.25₹2.25
28 Jul 2014—₹2.25₹2.25
20 Aug 2013—₹2.25₹2.25
6 Aug 2012—₹2.00₹2.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
54
11 open-market of the newest 54
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
9 Jun 2022Melarkode Ganesan ParameswaranDirectorBuy3.7K₹9.1L246.593.7K → 3.7K0.00%0.00 pp7(2)told 8 Jun 2022
23 Mar 2018DR.SATISH S.UGRANKARDirectorSell9.5K₹23.9L252.383.46L → 3.37L0.19%-0.01 pp7(2)told 23 Mar 2018
23 Mar 2018DR.SATISH S.UGRANKARDirectorSell20.5K₹53.8L261.663.67L → 3.46L0.20%-0.01 pp7(2)told 23 Mar 2018
20 Sept 2017DR.SATISH S.UGRANKARDirectorSell1.0K₹1.7L171.583.68L → 3.67L0.21%-0.00 pp7(2)told 20 Sept 2017
19 Sept 2017DR.SATISH S.UGRANKARDirectorSell6.3K₹10.8L172.933.74L → 3.68L0.21%-0.00 pp7(2)told 19 Sept 2017
16 Sept 2017DR.SATISH S.UGRANKARDirectorSell4.0K₹6.9L171.503.78L → 3.74L0.21%-0.00 pp7(2)told 16 Sept 2017
16 Sept 2017DR.SATISH S.UGRANKARDirectorSell2.2K₹3.8L173.513.80L → 3.78L0.21%-0.00 pp7(2)told 15 Sept 2017
14 Sept 2017DR.SATISH S.UGRANKARDirectorSell1.5K₹2.7L176.833.82L → 3.80L0.21%-0.00 pp7(2)told 13 Sept 2017
8 Sept 2017DR.SATISH S.UGRANKARDirectorSell3.5K₹5.9L168.563.86L → 3.82L0.21%-0.00 pp7(2)told 6 Sept 2017
2 Sept 2017DR.SATISH S.UGRANKARDirectorSell9.0K₹15.1L166.793.95L → 3.86L0.22%-0.01 pp7(2)told 1 Sept 2017
1 Sept 2017DR.SATISH S.UGRANKARDirectorSell7.4K₹12.4L166.664.02L → 3.95L0.22%-0.00 pp7(2)told 31 Aug 2017

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 12 Sept 2024

CSV
7 of 7 deals
By year
DateDealClientQuantityPriceValue
12 Sept 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP10.75L631.92₹68.0Cr
12 Sept 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP10.75L631.46₹67.9Cr
20 Feb 2009Sell · bulkMERRILL LYNCH CAPITAL MARKETS ESPANA S.A. SVB15.07L30.65₹4.6Cr
20 Feb 2009Buy · bulkPRIVATBANK IHAG ZURICH AG15.07L30.65₹4.6Cr
22 Nov 2004Buy · bulkRELIANCE CAPITAL TRUSTEE CO. LTD A/C RELIANCE PHARMA FUND20.00L52.50₹10.5Cr
22 Nov 2004Sell · bulkASHOK ANAND CHANDAVARKAR (AW) (BB)11.00L52.50₹5.8Cr
22 Nov 2004Sell · bulkMANGALA ASHOK CHANDAVARKAR (AW) (BB)11.00L52.50₹5.8Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to FDC.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations458.2462.0638.3513.8464.1491.9648.4473.0464.7584.8667.7572.1
Other income24.720.328.434.718.816.135.520.620.849.947.717.9
Total income482.9482.3666.7548.5482.9508.0683.9493.7485.5634.7715.4590.1
Total expenses385.3417.1504.0458.6431.8454.7524.1455.6428.3494.3540.7524.7
└ Finance costs1.01.01.31.10.91.21.21.21.11.50.80.8
└ Depreciation10.010.411.013.813.415.614.915.214.814.415.116.0
Profit before tax97.565.2162.790.051.253.3159.838.136.4140.4174.765.4
Tax expense18.418.943.718.014.114.638.49.78.137.042.216.4
Net profit79.246.3119.072.037.038.7121.428.428.3103.4132.549.1
EPS4.862.847.314.432.282.387.451.751.746.358.143.01
Net margin17.28%10.02%18.65%14.02%7.98%7.86%18.72%6.00%6.09%17.68%19.84%8.57%
PBT margin21.29%14.11%25.50%17.51%11.03%10.84%24.64%8.05%7.83%24.00%26.16%11.43%
Tax rate18.83%29.02%26.85%19.95%27.62%27.46%24.05%25.51%22.21%26.33%24.16%25.00%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 27 Oct 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets2,342.92,341.72,468.12,688.12,713.82,885.62,919.03,175.7
Current assets1,066.61,004.91,112.41,143.61,085.31,130.21,132.51,197.0
└ Cash & equivalents23.922.525.444.451.535.648.736.2
└ Other bank balances1.10.90.91.11.30.81.311.0
└ Current investments457.3359.3450.0545.2484.7388.7472.7574.9
└ Trade receivables122.6158.6117.4173.5108.8164.3151.7153.6
└ Inventories328.5341.0388.9322.8375.0435.1355.3301.8
Total equity1,981.41,971.82,097.22,291.72,281.12,431.42,485.12,668.9
└ Attributable to owners1,982.01,972.52,097.22,291.72,281.12,431.42,485.12,668.9
└ Non-controlling interest(0.6)(0.7)0.0—————
└ Share capital16.616.316.316.316.316.316.316.3
Borrowings0.60.50.30.00.10.00.00.0
└ Current0.10.00.00.00.00.00.00.0
└ Non-current0.60.50.20.00.10.00.00.0
Trade payables178.5168.0186.0171.5205.2214.1206.8250.7
Current liabilities311.6320.9310.6330.4361.6380.0364.1433.7
Total liabilities361.5369.8370.9396.4432.7454.2433.9506.8
Net debt(481.6)(382.1)(476.0)(590.8)(537.3)(425.1)(522.7)(622.1)
Debt / equity0.000.000.000.000.000.000.000.00
Current ratio3.423.133.583.463.002.973.112.76

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow154.9125.2220.8224.7317.6(1.9)200.5251.3
└ Capex(113.1)(56.7)(93.4)(30.9)(96.7)(81.4)(186.6)(155.3)
Free cash flow41.868.6127.4193.8220.8(83.4)13.995.9
Investing cash flow11.170.2(17.1)(200.0)(199.5)(6.8)(109.9)(259.4)
Financing cash flow(180.0)(197.0)(202.2)(5.7)(92.1)(7.1)(93.3)(4.4)
└ Dividends paid0.00.0(0.1)0.0(81.1)0.0(81.0)(0.1)
└ Buybacks(169.6)(191.7)(191.8)0.00.00.00.00.0
Net change in cash(13.8)(1.6)1.519.026.1(15.9)(2.8)(12.5)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

FDC at a glance

  • FDC closed at ₹377.55 on 20 Nov 2026, -0.13% on the day, -7.6% over one year, 14.6% below its 52-week high of ₹442.
  • Delivery was 28.5% of traded quantity on 20 Nov 2026, the 3rd percentile of its own 3,629 sessions with a reading (20-session average 50.7%, 1-year average 54.4%).
  • Market capitalisation is ₹6,147 crore at a trailing P/E of 19.6 (trailing EPS ₹19.24).
  • Q2 FY27 results (consolidated, filed 27 Oct 2026): revenue ₹572 crore (+21.0% year on year), net profit ₹49 crore (+72.9%); the price moved +6.4% on the first session after.
  • Promoters held 69.66% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 5 Feb 2027 and 13 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE258B01022
SeriesEQ
Listed7 Aug 1997
NSE market cap · 17 Nov 2026₹6,120 Cr
Free-float market cap (NSE)₹1,840 Cr
Shares outstanding (NSE)16.28Cr
History from7 Aug 1997
Sessions7,187
Turnover rank#929

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.